Marketing strategist leading a fintech team through an AI citation review
AI Marketing

How Fintech and Life Science Brands Get Cited by ChatGPT and Perplexity

By, Carlos Rios
  • 5 Oct, 2026
  • 84 Views
  • 0 Comment

Fintech and life science brands get cited by ChatGPT and Perplexity through entity signals and specific positioning, not cautious copy. FINRA’s 2026 proposal to modernize AI-content review and FDA’s unresolved guidance gap both show regulators moving faster on AI than most marketing teams assume.

Why Fintech and Life Science Brands Get Overlooked by ChatGPT and Perplexity

Not because of regulation. Marketing teams in both industries routinely write their way out of citations before compliance ever reviews a word defaulting to vague, legal-safe copy on the assumption that specificity equals risk. ChatGPT and Perplexity retrieve by entity and topic association, not caution; a brand with no Wikipedia or Wikidata presence and no earned press mentions is invisible to a model regardless of how careful the copy reads.

ConvertMate’s analysis puts Wikipedia at 7.8% of all ChatGPT citations, and SE Ranking’s domain study found brands with heavy Reddit presence average 7 ChatGPT citations against 1.8 for low-presence domains — a 3.9x gap that has nothing to do with regulatory caution.

How Do Fintech Brands Actually Get Cited by ChatGPT and Perplexity?

FINRA’s July 2026 Regulatory Notice 26-14 proposes replacing mandatory pre-use principal approval with a risk-based supervisory framework for AI-generated communications, because the existing process has become difficult to apply at AI’s publishing speed. Firms remain fully responsible for AI-generated content regardless of who drafted it — the SEC Marketing Rule (206(4)-1) still governs every piece of advertising a firm publishes.

What this changes for marketing: the bottleneck was never “can we publish an opinionated claim,” it’s “do we have a documented review workflow that moves at AI-driven search speed.” A brand that builds that workflow once can publish the specific claims that actually get cited. One that treats “regulated” as a reason to stay generic is competing against agencies already publishing fintech benchmark data that outrank most fintech brands themselves in citation share — FirstPageSage and Omnius together account for roughly 5% of fintech AI citations, behind only Wikipedia.

How Do Life Science Brands Actually Get Cited by ChatGPT and Perplexity?

Carefully, into a guidance gap FDA hasn’t closed yet. As of early 2026, FDA’s AI guidance covers drug development, not advertising or promotion. Meanwhile the agency has been using its own AI tool, Elsa, to help expedite review of submissions and promotional material since June 2025.

That gap isn’t permission to go quiet. AI-generated promotional content still has to clear the same fair-balance and risk-disclosure standards as anything else, and OPDP has kept citing violations across HCP websites, influencer content, and earned media through early 2026. The brands earning citations now are publishing a dated, specific account of how they handle AI-generated promotional content inside those existing standards — the first-hand detail a generic “AI and compliance” overview never includes.

Life science marketing lead reviewing a content workflow

What Should Fintech and Life Science Brands Do First?

Fix entity signals before adding content volume. Confirm Organization+SameAs schema is live sitewide, check for a Wikipedia or Wikidata entry, and secure at least one earned mention this quarter — on-page quality alone rarely moves citation inclusion without it.

This is the same foundation work covered in Tabula’s Marketing Ownership Framework: the system has to be something the brand owns and controls, not something rebuilt from scratch every time a channel shifts.

Strategist walking a client team through their marketing ownership framework

Then write what nobody else in the category has: a dated, specific explanation of what the regulatory shift actually changes for a marketing team’s workflow — not a generic compliance overview. That’s the asset a model has a retrieval reason to cite, built on the fundamentals covered in getting your brand cited by AI and how GEO differs from traditional SEO. Expect 4 to 8 weeks between publishing and appearing in answers — Perplexity typically surfaces new citations faster than ChatGPT.

See how Tabula’s GEO services approach this system if the entity-signal gap above sounds familiar.

FAQ

How do I get my fintech brand cited by ChatGPT or Perplexity?

Fix entity signals first: Organization schema, a Wikipedia or Wikidata presence, and earned press mentions outweigh content volume. Then publish specific, dated content about how your firm handles AI-generated communications under the SEC Marketing Rule and FINRA’s current framework — a gap most fintech competitors haven’t filled.

How do I get my life science brand cited by ChatGPT and Perplexity?

Publish a dated, specific account of how your team handles AI-generated promotional content within FDA’s existing fair-balance and risk-disclosure standards. That specificity is the first-hand detail a generic competitor post skips, and it’s what gives a model a reason to cite you over them.

Does FINRA allow AI-generated marketing content?

Yes. FINRA has not prohibited AI-generated communications; firms remain fully responsible for them regardless of who drafted them. The 2026 proposal to modernize Rule 2210 would shift supervision toward a risk-based framework rather than removing oversight entirely.

Does the FDA have rules for AI-generated life science marketing content?

Not specifically yet. FDA’s current AI guidance covers drug development, not advertising or promotion. AI-generated promotional content still has to meet the same fair-balance, risk-disclosure, and human-review standards as any other promotional material.

How long does it take to start appearing in AI citations after publishing?

Typically 4 to 8 weeks, with Perplexity generally surfacing new or updated content faster than ChatGPT, since Perplexity searches in real time rather than relying on a training snapshot.

Your compliance team isn’t the problem. Your entity signals are.


Tabula builds the AI citation system fintech and life science brands can own, not rebuild every time a rule changes.


See how Tabula approaches GEO

Carlos Rios

Author

Carlos Rios

Carlos Rios is the Founder of Tabula. Before starting the agency, he spent his career inside companies — reporting to leaders who had no patience for vanity metrics and wanted straight answers about what was working and why. He built Tabula around that same standard: a marketing system the client owns, powered by AI and led by experts who explain the plan in plain language. Carlos studied philosophy for six years at York University and holds a Master's in Marketing from the Schulich School of Business.